ESG

Data shows Beren Therapeutics' drug slows progression and boosts survival for infantile-onset NPC, a rare disorder with no approved US treatments.

Amid a complex healthcare market, The Ensign Group will outline its aggressive growth and operational playbook for investors at the upcoming Oppenheimer conference.

With a new strategic finance leader, MATEREAL signals a shift from R&D to aggressive commercialization of its 'drop-in' AI-enabled bio-polymers.

A legislative movement across 11 states aims to make scalp cooling, a therapy to prevent hair loss during chemo, an insured part of cancer treatment.

A new billboard campaign by an evangelical group thanks Trump for his leadership during the ongoing war with Iran, highlighting his enduring political influence.

Wanda Duran's national award highlights her impact on quality and mentorship, revealing a broader shift in the manufacturing industry's future.

The veteran cycling outfitter is launching guided hiking, paddling, and gourmet camping trips, tapping into a surging demand for accessible wilderness luxury.

New AI-powered features are transforming phone calls for people with hearing or speech disabilities, boosting confidence and making conversations feel natural.

A new report reveals a massive care gap for 76 million US cats, offering a $34 billion roadmap for vets to boost revenue and improve feline health.

A new partnership combines advanced AI with human expertise to bring hope and clarity to 300 million people on a long, isolating journey to diagnosis.

A global campaign is rebranding the canned sardine as a weapon against metabolic disease. We investigate the science, the strategy, and a $12 wellness plan.

A new sculpture by artists Pierre and Cedric Koukjian atop a former civil war sniper's nest aims to mend historical divides and redefine Beirut's future.

Enterprises are racing to deploy AI agents, but a lack of visibility is eroding trust. A new class of tools aims to prevent costly failures.

A groundbreaking clinical trial shows a nutrition-based therapy extended life by 34% in stage IV pancreatic cancer patients, offering rare hope.

Pita giant Joseph's Bakery is relaunching the Tumaro's wrap brand with new Keto Certified flavors, aiming to dominate the health-conscious food space.

Theriva Biologics pushes its promising cancer virus toward pivotal trials, but an auditor's 'going concern' warning raises questions about its future.

The biopharma nonprofit will tackle clinical trial modernization, AI integration, and the unfulfilled promise of real-world evidence at a key industry summit.

A global industrial giant's 10-14% surcharge reveals the direct line from Mideast conflict to higher costs for your local hospital and restaurant.

The specialty infusion provider is the first to earn a rigorous new distinction, signaling a major leap forward in patient safety and quality of care.

The precision oncology firm reports a dramatic cut in net loss and a strategic pivot paying off, bolstered by a new U.S. patent for its cancer tech.